Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005257904 (hide)

Owner Merck & Co., Inc.

Inventors Coburn, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005257904

PCT Pub. Number WO2006/002004

Priority 60/579,794 15.06.04 US

Filing date 10 June 2005

Wipo publication date 5 January 2006

International Classifications

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002004 Priority application(s): WO2006/002004

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257915-Dry-forming three-dimensional wood fiber webs

2005257893-Spinal rod system